Adverse drug events associated with tiotropium: a real-world pharmacovigilance study of FDA adverse event reporting system database
IntroductionTiotropium, a long-acting muscarinic antagonist, is commonly employed for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma. While its efficacy has been validated through numerous randomized controlled trials, safety concerns in real-world post-marketin...
| Published in: | Journal of Pharmacy & Pharmaceutical Sciences |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Subjects: | |
| Online Access: | https://www.frontierspartnerships.org/articles/10.3389/jpps.2025.14917/full |
